MedPath
HSA Approval

DEXCOPHAN COUGH LINCTUS PLUS

SIN07643P

DEXCOPHAN COUGH LINCTUS PLUS

DEXCOPHAN COUGH LINCTUS PLUS

February 8, 1994

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

ELIXIR

ORAL

Medical Information

R05FB02

cough suppressants and expectorants

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

HOVID BHD

Active Ingredients

AMMONIUM CHLORIDE

150 mg/5 ml

Ammonium chloride

EPHEDRINE HCl

6.25 mg/5 ml

Ephedrine

DEXTROMETHORPHAN HBr

10 mg/5 ml

Dextromethorphan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DEXCOPHAN COUGH LINCTUS PLUS - HSA Approval | MedPath